非特异性CXCR7抗体。 - Suppr

Suppr

超能文献

Nonspecific CXCR7 antibodies.

作者信息

Berahovich Robert D, Penfold Mark E T, Schall Thomas J

出版信息

Immunol Lett. 2010 Oct 30;133(2):112-4. doi: 10.1016/j.imlet.2010.06.010. Epub 2010 Aug 6.

DOI:10.1016/j.imlet.2010.06.010

PMID:20691730

Abstract

摘要

相似文献

Nonspecific CXCR7 antibodies.

Immunol Lett. 2010 Oct 30;133(2):112-4. doi: 10.1016/j.imlet.2010.06.010. Epub 2010 Aug 6.

Complementary methods provide evidence for the expression of CXCR7 on human B cells.

Proteomics. 2012 Jun;12(12):1938-48. doi: 10.1002/pmic.201100581.

Pathogenic role of CXCR7 in rheumatoid arthritis.

Arthritis Rheum. 2010 Nov;62(11):3211-20. doi: 10.1002/art.27650.

Differences in CXCR7 protein expression on rat versus mouse and human splenic marginal zone B cells.

Immunol Lett. 2013 Jul-Aug;154(1-2):77-9. doi: 10.1016/j.imlet.2013.08.004. Epub 2013 Aug 14.

CXCR7 is up-regulated in human and murine hepatocellular carcinoma and is specifically expressed by endothelial cells.

Eur J Cancer. 2012 Jan;48(1):138-48. doi: 10.1016/j.ejca.2011.06.044. Epub 2011 Jul 19.

CXCR7 mediated Giα independent activation of ERK and Akt promotes cell survival and chemotaxis in T cells.

Cell Immunol. 2012;272(2):230-41. doi: 10.1016/j.cellimm.2011.09.015. Epub 2011 Oct 20.

CXCR7 Mediates Neural Progenitor Cells Migration to CXCL12 Independent of CXCR4.

Stem Cells. 2015 Aug;33(8):2574-85. doi: 10.1002/stem.2022. Epub 2015 May 13.

The presumed atypical chemokine receptor CXCR7 signals through G(i/o) proteins in primary rodent astrocytes and human glioma cells.

Glia. 2012 Mar;60(3):372-81. doi: 10.1002/glia.22271. Epub 2011 Nov 14.

Differential expression of RDC1/CXCR7 in the human placenta.

J Clin Immunol. 2009 May;29(3):379-86. doi: 10.1007/s10875-008-9258-4. Epub 2008 Oct 28.

CXCR7 impact on CXCL12 biology and disease.

Trends Mol Med. 2013 Jan;19(1):12-22. doi: 10.1016/j.molmed.2012.10.004. Epub 2012 Nov 12.

引用本文的文献

Heterogeneous expression of the atypical chemokine receptor ACKR3 in glioblastoma patient-derived tissue samples and cell cultures.

Sci Rep. 2024 Sep 20;14(1):21925. doi: 10.1038/s41598-024-73064-w.

Advances in CXCR7 Modulators.

Pharmaceuticals (Basel). 2020 Feb 21;13(2):33. doi: 10.3390/ph13020033.

Nociceptin/Orphanin FQ (N/OFQ) conjugated to ATTO594: a novel fluorescent probe for the N/OFQ (NOP) receptor.

Br J Pharmacol. 2018 Dec;175(24):4496-4506. doi: 10.1111/bph.14504. Epub 2018 Nov 6.

Targeted Imaging of the Atypical Chemokine Receptor 3 (ACKR3/CXCR7) in Human Cancer Xenografts.

J Nucl Med. 2016 Jun;57(6):981-8. doi: 10.2967/jnumed.115.167932. Epub 2016 Feb 23.

Commercially available antibodies directed against α-adrenergic receptor subtypes and other G protein-coupled receptors with acceptable selectivity in flow cytometry experiments.

Naunyn Schmiedebergs Arch Pharmacol. 2016 Feb;389(2):243-8. doi: 10.1007/s00210-015-1196-0. Epub 2015 Dec 14.

CXCR7 functions in colon cancer cell survival and migration.

Exp Ther Med. 2015 Nov;10(5):1720-1724. doi: 10.3892/etm.2015.2748. Epub 2015 Sep 15.

Identification of chemokine receptors as potential modulators of endocrine resistance in oestrogen receptor-positive breast cancers.

Breast Cancer Res. 2014 Oct 31;16(5):447. doi: 10.1186/s13058-014-0447-1.

Chemokine (C-X-C motif) receptor 4 and atypical chemokine receptor 3 regulate vascular α₁-adrenergic receptor function.

Mol Med. 2014 Oct 13;20(1):435-47. doi: 10.2119/molmed.2014.00101.

Evaluation of commercial antibodies against human sphingosine-1-phosphate receptor 1.

Naunyn Schmiedebergs Arch Pharmacol. 2014 May;387(5):427-31. doi: 10.1007/s00210-014-0957-5. Epub 2014 Jan 24.

Endothelial expression of CXCR7 and the regulation of systemic CXCL12 levels.

Immunology. 2014 Jan;141(1):111-22. doi: 10.1111/imm.12176.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Nonspecific CXCR7 antibodies.

作者信息

Berahovich Robert D, Penfold Mark E T, Schall Thomas J

出版信息

Immunol Lett. 2010 Oct 30;133(2):112-4. doi: 10.1016/j.imlet.2010.06.010. Epub 2010 Aug 6.

DOI:10.1016/j.imlet.2010.06.010

PMID:20691730

Abstract

摘要

相似文献

Nonspecific CXCR7 antibodies.

Immunol Lett. 2010 Oct 30;133(2):112-4. doi: 10.1016/j.imlet.2010.06.010. Epub 2010 Aug 6.

Complementary methods provide evidence for the expression of CXCR7 on human B cells.

Proteomics. 2012 Jun;12(12):1938-48. doi: 10.1002/pmic.201100581.

Pathogenic role of CXCR7 in rheumatoid arthritis.

Arthritis Rheum. 2010 Nov;62(11):3211-20. doi: 10.1002/art.27650.

Differences in CXCR7 protein expression on rat versus mouse and human splenic marginal zone B cells.

Immunol Lett. 2013 Jul-Aug;154(1-2):77-9. doi: 10.1016/j.imlet.2013.08.004. Epub 2013 Aug 14.

CXCR7 is up-regulated in human and murine hepatocellular carcinoma and is specifically expressed by endothelial cells.

Eur J Cancer. 2012 Jan;48(1):138-48. doi: 10.1016/j.ejca.2011.06.044. Epub 2011 Jul 19.

CXCR7 mediated Giα independent activation of ERK and Akt promotes cell survival and chemotaxis in T cells.

Cell Immunol. 2012;272(2):230-41. doi: 10.1016/j.cellimm.2011.09.015. Epub 2011 Oct 20.

CXCR7 Mediates Neural Progenitor Cells Migration to CXCL12 Independent of CXCR4.

Stem Cells. 2015 Aug;33(8):2574-85. doi: 10.1002/stem.2022. Epub 2015 May 13.

The presumed atypical chemokine receptor CXCR7 signals through G(i/o) proteins in primary rodent astrocytes and human glioma cells.

Glia. 2012 Mar;60(3):372-81. doi: 10.1002/glia.22271. Epub 2011 Nov 14.

Differential expression of RDC1/CXCR7 in the human placenta.

J Clin Immunol. 2009 May;29(3):379-86. doi: 10.1007/s10875-008-9258-4. Epub 2008 Oct 28.

CXCR7 impact on CXCL12 biology and disease.

Trends Mol Med. 2013 Jan;19(1):12-22. doi: 10.1016/j.molmed.2012.10.004. Epub 2012 Nov 12.

引用本文的文献

Heterogeneous expression of the atypical chemokine receptor ACKR3 in glioblastoma patient-derived tissue samples and cell cultures.

Sci Rep. 2024 Sep 20;14(1):21925. doi: 10.1038/s41598-024-73064-w.

Advances in CXCR7 Modulators.

Pharmaceuticals (Basel). 2020 Feb 21;13(2):33. doi: 10.3390/ph13020033.

Nociceptin/Orphanin FQ (N/OFQ) conjugated to ATTO594: a novel fluorescent probe for the N/OFQ (NOP) receptor.

Br J Pharmacol. 2018 Dec;175(24):4496-4506. doi: 10.1111/bph.14504. Epub 2018 Nov 6.

Targeted Imaging of the Atypical Chemokine Receptor 3 (ACKR3/CXCR7) in Human Cancer Xenografts.

J Nucl Med. 2016 Jun;57(6):981-8. doi: 10.2967/jnumed.115.167932. Epub 2016 Feb 23.

Commercially available antibodies directed against α-adrenergic receptor subtypes and other G protein-coupled receptors with acceptable selectivity in flow cytometry experiments.

Naunyn Schmiedebergs Arch Pharmacol. 2016 Feb;389(2):243-8. doi: 10.1007/s00210-015-1196-0. Epub 2015 Dec 14.

CXCR7 functions in colon cancer cell survival and migration.

Exp Ther Med. 2015 Nov;10(5):1720-1724. doi: 10.3892/etm.2015.2748. Epub 2015 Sep 15.

Identification of chemokine receptors as potential modulators of endocrine resistance in oestrogen receptor-positive breast cancers.

Breast Cancer Res. 2014 Oct 31;16(5):447. doi: 10.1186/s13058-014-0447-1.

Chemokine (C-X-C motif) receptor 4 and atypical chemokine receptor 3 regulate vascular α₁-adrenergic receptor function.

Mol Med. 2014 Oct 13;20(1):435-47. doi: 10.2119/molmed.2014.00101.

Evaluation of commercial antibodies against human sphingosine-1-phosphate receptor 1.

Naunyn Schmiedebergs Arch Pharmacol. 2014 May;387(5):427-31. doi: 10.1007/s00210-014-0957-5. Epub 2014 Jan 24.

Endothelial expression of CXCR7 and the regulation of systemic CXCL12 levels.

Immunology. 2014 Jan;141(1):111-22. doi: 10.1111/imm.12176.